Henggliejin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Henggliejin, covering 2025-09-30 to 2025-09-30. Get the full timeline:
Most recent: Clinical Trial Update: The Improvement Effect of Henggliejin on Fatty Liver in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver: [EARLY_Phase 1]